Attached files

file filename
10-K - FORM 10-K - PATHEON INCpatheon201110k.htm
EX-21.1 - SUBSIDIARIES OF PATHEON - PATHEON INCexhibit211.htm
EX-23.1 - CONSENT OF ERNST & YOUNG LLP - PATHEON INCexhibit231.htm
EX-10.31 - SEVERANCE & GENERAL RELEASE AGREEMENT BETWEEN PATHEON PHARMACEUTICALS SERVICES INC. AND ERIC EVANS - PATHEON INCexhibit1031.htm
EX-10.22 - THE PATHEON GLOBAL BONUS PLAN - PATHEON INCexhibit1022.htm
EX-10.40 - SECOND AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN PATHEON PHARMACEUTICALS SERVICES INC. AND PAUL M. GAROFOLO - PATHEON INCexhibit1040.htm
EX-10.49 - EMPLOYMENT AGREEMENT BETWEEN REBECCA HOLLAND NEW AND PATHEON PHARMACEUTICALS SERVICES INC. - PATHEON INCexhibit1049.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - PATHEON INCsection906ceocertification.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - PATHEON INCsection302cfocertification.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - PATHEON INCsection302ceocertification.htm


Exhibit 32.2
Certification by the Principal Financial Officer
pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report on Form 10-K of Patheon Inc. (the “Company”) for the period ended October 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Dean F. Wilson, Vice President, Corporate Controller of the Company, hereby certifies, to the knowledge of the undersigned, pursuant to 18 U.S.C. Section 1350, that:

(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
Date: December 19, 2011
 
/s/ Dean F. Wilson
 
 
Dean F. Wilson
 
 
Vice President, Corporate Controller
(Principal Financial Officer)
This Certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing.
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.